Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Involving Field Radiotherapy in Oligo-metastatic Ovarian Cancer
NCT05059782Unknown
- Sponsor
- Xi'an Jiaotong University
- Start
- Oct 2021
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Xi'an Jiaotong University. Primary endpoint: Local Control at 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT05059782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05059782.